<p align=center>Email sended at 06-09-2017 13:18:20</p>
              	<li>to:</li>
                <li>headers:From: comitati-etici-toscana@no-reply.it<comitati-etici-toscana@no-reply.it>
BCC: g.contino@cineca.it
CC: sclafanin@aou-careggi.toscana.it
Reply-To: <>
Return-Path: comitati-etici-toscana@no-reply.it<comitati-etici-toscana@no-reply.it>
Message-ID: <1504703900-comitati-etici-toscana@no-reply.it>
MIME-Version: 1.0
Content-Type: multipart/mixed;
 boundary="c5e0b41a791bcc7bc1ef7315dcc26176"

</li>
                <li>oggetto:Segreteria CEAV Centro - notifica di parere positivo</li>
                <li>testo:La segreteria CEAV Centro ha inviato parere positivo per lo studio 'Assessment of Ramucirumab plus paclitaxel as switch MANteInance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III Trial.'.<br> E' possibile visualizzarne i dettagli tramite il seguente link:<br> <a href="https://ricercaclinica-toscana.cineca.it/uxmr/index.php?&exams=visite_exam.xml&ID_STUD=10834">Vai allo studio</a>&nbsp;</li>
                <hr><p align=center>Email sended at 06-09-2017 13:26:37</p>
              	<li>to:</li>
                <li>headers:From: comitati-etici-toscana@no-reply.it<comitati-etici-toscana@no-reply.it>
BCC: g.contino@cineca.it
CC: sclafanin@aou-careggi.toscana.it
Reply-To: <>
Return-Path: comitati-etici-toscana@no-reply.it<comitati-etici-toscana@no-reply.it>
Message-ID: <1504704397-comitati-etici-toscana@no-reply.it>
MIME-Version: 1.0
Content-Type: multipart/mixed;
 boundary="90e09a05c3e99422a8d9e1eb0adccd87"

</li>
                <li>oggetto:Segreteria CEAV Centro - notifica di parere positivo</li>
                <li>testo:La segreteria CEAV Centro ha inviato parere positivo per lo studio 'Assessment of Ramucirumab plus paclitaxel as switch MANteInance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III Trial.'.<br> E' possibile visualizzarne i dettagli tramite il seguente link:<br> <a href="https://ricercaclinica-toscana.cineca.it/uxmr/index.php?&exams=visite_exam.xml&ID_STUD=10834">Vai allo studio</a>&nbsp;</li>
                <hr>